Synchron, a leader in non-surgical brain-computer interface (BCI) technology, announced today it has raised a $200 million Series D financing round. The funding will accelerate commercialization of ...
The funds are expected to accelerate commercialization of the company’s Stentrode BCI platform, while advancing development ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback